The Genetics Podcast
EP 143: Harnessing human data in drug development with Jakob Steinfeldt, Co-Founder and Chief Scientific Officer at Pheiron
Episode notes
0:00 Intro to The Genetics Podcast
01:00 Welcome to Jakob and background on Pheiron
02:14 What made Jakob decide to start Pheiron, what the company does, and how his scientific background inspired him to found a start-up
5:24 Jakob’s excitement and inspiration around the power and potential of machine learning
07:07 Cardiology and heart failure as an example of the gap between where research needs to be compared to where it is today
10:52 Why creating the GPS for identifying patients at increased risk of disease is a challenge on multiple fronts
12:42 How Pheiron’s approach and specificity is opening up the possibility of identifying highly-relevant patients and running clinical trials at greater pace
17.35 How testing potential treatments in a highly-specific population affects the design of Phase 3 clinical trials
21:19 The types of data required to build Pheiron’s GPS - from population scale insights to deep analysis within subgroups
23:48 Whether there is a shortage of healthcare systems with robust research arms looking to participate in such collaborations
27:30 Working with patients to build a collaborative commitment to data sharing
28:22 Making the decision to start Pheiron rather than continue working in medicine or research
30:38 Core learnings from building a company from the ground up
31:35 What Jakob is currently most focused on and what he hopes to achieve with Phieron in the immediate future
34:40 Closing remarks
Please consider rating and reviewing us on your chosen podcast listening platform!
Find out more:
Find Jakob on Twitter (X)